ストックスクリーナーアプリを入手
3.07
0.66%
0.02
前日終値:
$3.05
開ける：
$3.03
24時間の取引高:
367.77K
Relative Volume:
1.60
時価総額：
$104.45M
収益：
$210.00K
当期純損益:
$-10.12M
株価収益率:
-10.13
EPS:
-0.3032
ネットキャッシュフロー:
$-7.12M
1週間 パフォーマンス:
-11.78%
1か月 パフォーマンス:
-9.97%
6か月 パフォーマンス:
+5.50%
1年 パフォーマンス:
+3.37%
1日の値動き範囲:
$3.00
$3.105
1週間の範囲:
$2.99
$3.63
52週間の値動き範囲:
$2.32
$5.4566
Anixa Biosciences Inc Stock (ANIX) Company Profile
名前
Anixa Biosciences Inc
セクター
電話
408-708-9808
住所
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Compare ANIX vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
3.07 | 122.14M | 210.00K | -10.12M | -7.12M | -0.3032 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | 開始されました | Maxim Group | Buy |
| 2022-12-23 | 開始されました | Chardan Capital Markets | Buy |
| 2021-04-12 | 開始されました | H.C. Wainwright | Buy |
Anixa Biosciences Inc (ANIX) 最新ニュース
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research - MarketBeat
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - simplywall.st
Anixa (ANIX) Range: Slides 2.70% to $3.61 in the Latest Reading; Level Watch - vinanet.vn
Anixa (ANIX) Latest Results Brief: EPS Prints Above Forecast at the Close; Post-Earnings Trading: Shares Finish 3.30% Lower in the Latest ReadingEBITDA Analysis - vinanet.vn
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Anixa Biosciences (ANIX) Surges 7.7% as Biotech Momentum BuildsCorrective Wave - vinanet.vn
Anixa Biosciences (ANIX) Slips 0.63% to $3.18 as Shares Consolidate Between Key Support and ResistancePre-Earnings Momentum - vinanet.vn
Anixa Biosciences (ANIX) Holds Near $3.42 as Traders Eye Key Support and Resistance LevelsVolatility Term Structure - vinanet.vn
Anixa Biosciences (NASDAQ:ANIX) CEO Amit Kumar Buys 5,000 Shares - MarketBeat
Anixa Biosciences (ANIX) CEO Amit Kumar Buys 5,000 Shares, Insider Ownership Climbs to 657,000 Shares - GuruFocus
Anixa Biosciences CEO Amit Kumar buys $17,350 in company stock By Investing.com - Investing.com Nigeria
Form 4 Anixa Biosciences Inc For: 3 August By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 5,000 company shares - Stock Titan
Anixa Biosciences CEO Amit Kumar acquires 5,000 common shares valued at $17,350 - Bitget
Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Form 4 Anixa Biosciences Inc For: 29 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) director exercises 6,000 options, uses 5,428 shares to pay cost - Stock Titan
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires $17,200.00 in Stock - MarketBeat
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires 3,000 Shares - MarketBeat
Anixa Biosciences (NASDAQ: ANIX) CEO buys 5,000 shares, now holds 652,000 - Stock Titan
Anixa Biosciences Inc (ANIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Form 4 Anixa Biosciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 3,188 shares at $3.37 each - Stock Titan
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock - Investing.com
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock By Investing.com - Investing.com Canada
Anixa Biosciences Inc (ANIX) CEO purchases 3,000 shares at $3.73 - Stock Titan
Anixa Biosciences Inc (ANIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anixa Biosciences Inc (ANIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anixa Biosciences, Inc. Revenue Breakdown – NASDAQ:ANIX - TradingView
Anixa Biosciences Inc (ANIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.700|Chg%:-0.050 - TradingKey
TradingKey - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.725|Chg%:+0.025 - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.680|Chg%:-0.020 - TradingKey
Anixa Biosciences Inc (ANIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance UK
New Strong Buy Stocks for July 22nd - The Globe and Mail
CEO Amit Kumar Increases Stake in Anixa Biosciences Inc - GuruFocus
3 Penny Stocks With Market Caps Over $100M To Consider - Sahm
Anixa Biosciences (ANIX) CEO buys 5,000 common shares - Stock Titan
Anixa Biosciences Inc. (ANIX) Q2 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline Advances - dars.gov.et
Insider Buying: Titterton Lewis H Jr Acquires Additional Shares of Anixa Biosciences Inc (ANIX) - GuruFocus
Anixa Biosciences (ANIX) director purchases 12,000 shares of common stock - Stock Titan
Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance - AOL.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Anixa Biosciences Director Lewis H. Titterton Jr acquires $9,172 of common shares - Bitget
Anixa Biosciences director buys $9,174 in common stock By Investing.com - Investing.com South Africa
Insider Buying: Titterton Lewis H Jr Increases Stake in Anixa Bi - GuruFocus
Anixa Biosciences director buys $9,174 in common stock - Investing.com
Form 4 Anixa Biosciences Inc For: 16 July By Investing.com - Investing.com Canada
Anixa Biosciences Inc (ANIX) 財務データ
収益
当期純利益
現金流量
EPS
Anixa Biosciences Inc (ANIX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Baskies Arnold M | Director |
Jul 27 '26 |
Option Exercise |
3.13 |
6,000 |
18,780 |
141,000 |
| KUMAR AMIT | Chief Executive Officer |
Jul 27 '26 |
Buy |
3.44 |
5,000 |
17,200 |
652,000 |
| KUMAR AMIT | Chief Executive Officer |
Jul 27 '26 |
Buy |
3.37 |
3,188 |
10,744 |
647,000 |
| KUMAR AMIT | Chief Executive Officer |
Jul 24 '26 |
Buy |
3.73 |
3,000 |
11,190 |
643,812 |
| KUMAR AMIT | Chief Executive Officer |
Jul 20 '26 |
Buy |
3.46 |
5,000 |
17,300 |
640,812 |
| Titterton Lewis H jr | Director |
Jul 20 '26 |
Buy |
3.47 |
12,000 |
41,640 |
986,967 |
| Titterton Lewis H jr | Director |
Jul 15 '26 |
Buy |
3.28 |
2,797 |
9,174 |
974,967 |
| KUMAR AMIT | Chief Executive Officer |
Jul 10 '26 |
Buy |
3.04 |
5,000 |
15,200 |
635,812 |
| Titterton Lewis H jr | Director |
Jun 16 '26 |
Buy |
2.64 |
2,836 |
7,487 |
972,170 |
| KUMAR AMIT | Chief Executive Officer |
Jun 12 '26 |
Buy |
2.50 |
21,000 |
52,500 |
630,812 |
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):